Long-term potentiation (LTP) at synapses between primary afferents and spinal dorsal horn neurons induced by noxious electrical stimulation or injury of peripheral nerve is considered to underlie chronic pain [1] . The mechanisms of the spinal LTP have been intensively investigated, since it was discovered in 1995 [2] . In recent years, spinal application of ATP [3], brain-derived neurotrophic factor (BDNF) [4] and opioid [5] has been shown to induce spinal LTP at C-fiber synapses in the absence of conditioning activation of primary afferents. This is contrary to the general belief that coincident pre-and postsynaptic activity is needed for LTP induction. Recently, Sandkühler and his co-workers reported in Science that combined activation of microglia and astrocytes by P 2 X 7 receptor agonist BzATP induces LTP at synapses between afferent C-fibers and spinal lamina I neurons in the absence of presynaptic activation, which is termed gliogenic LTP [6] (Fig. 1C) . To determine the relationship between the gliogenic LTP and high frequency stimulation (HFS)-induced LTP, they used transverse lumbar spinal cord slices with long dorsal roots which were separated into halves. Twenty two lamina I neurons that received independent monosynaptic C-fiber inputs from each dorsal root half were recorded. Homosynaptic LTP is recorded in 12 neurons, among them 6 neurons also show heterosynaptic LTP (Fig. 1A) . Interestingly, heterosynaptic LTP is also induced in 5 neurons in which HFS fails to induce homosynaptic LTP (Fig. 1B) . The data demonstrate that homo-and heterosynaptic LTP can be induced independently of each other in dorsal horn neurons. Importantly, they found that both homo-and heterosynaptic LTP depend on glial activation via activation of P 2 X 7 receptors, postsynaptic NMDA receptor and D-serine (a co-agonist of NMDA receptor) released from astrocytes. Accordingly, HFS-induced LTP may manifest as homo-and/or heterosynaptic LTP and both of them depend on the glial activation. Importantly, the gliogenic LTP can be transferred between individuals, i.e., application of spinal superfusate collected from lumbar segments of animals, in which the spinal LTP has been induced by HFS, onto spinal dorsal dorsum is able to induce LTP in naïve animals. The transferable LTP is prevented by blocking TNF-a, D-serine signaling and NMDA receptors but not by blocking glial activation in recipient animals. Accordingly, the spinal LTP is a result from the accumulated bioactive substances released by glial cells called gliotransmitters in activated sites, which may travel long distances via the cerebrospinal fluid and induce LTP in remote sites. The gliogenic LTP may underlie forms of widespread pain hypersensitivity, such as secondary hyperalgesia, pain amplification in uninjured sites.
Long-term potentiation (LTP) at synapses between primary afferents and spinal dorsal horn neurons induced by noxious electrical stimulation or injury of peripheral nerve is considered to underlie chronic pain [1] . The mechanisms of the spinal LTP have been intensively investigated, since it was discovered in 1995 [2] . In recent years, spinal application of ATP [3] , brain-derived neurotrophic factor (BDNF) [4] and opioid [5] has been shown to induce spinal LTP at C-fiber synapses in the absence of conditioning activation of primary afferents. This is contrary to the general belief that coincident pre-and postsynaptic activity is needed for LTP induction. Recently, Sandkühler and his co-workers reported in Science that combined activation of microglia and astrocytes by P 2 X 7 receptor agonist BzATP induces LTP at synapses between afferent C-fibers and spinal lamina I neurons in the absence of presynaptic activation, which is termed gliogenic LTP [6] (Fig. 1C) . To determine the relationship between the gliogenic LTP and high frequency stimulation (HFS)-induced LTP, they used transverse lumbar spinal cord slices with long dorsal roots which were separated into halves. Twenty two lamina I neurons that received independent monosynaptic C-fiber inputs from each dorsal root half were recorded. Homosynaptic LTP is recorded in 12 neurons, among them 6 neurons also show heterosynaptic LTP (Fig. 1A) . Interestingly, heterosynaptic LTP is also induced in 5 neurons in which HFS fails to induce homosynaptic LTP (Fig. 1B ). The data demonstrate that homo-and heterosynaptic LTP can be induced independently of each other in dorsal horn neurons. Importantly, they found that both homo-and heterosynaptic LTP depend on glial activation via activation of P 2 X 7 receptors, postsynaptic NMDA receptor and D-serine (a co-agonist of NMDA receptor) released from astrocytes. Accordingly, HFS-induced LTP may manifest as homo-and/or heterosynaptic LTP and both of them depend on the glial activation. Importantly, the gliogenic LTP can be transferred between individuals, i.e., application of spinal superfusate collected from lumbar segments of animals, in which the spinal LTP has been induced by HFS, onto spinal dorsal dorsum is able to induce LTP in naïve animals. The transferable LTP is prevented by blocking TNF-a, D-serine signaling and NMDA receptors but not by blocking glial activation in recipient animals. Accordingly, the spinal LTP is a result from the accumulated bioactive substances released by glial cells called gliotransmitters in activated sites, which may travel long distances via the cerebrospinal fluid and induce LTP in remote sites. The gliogenic LTP may underlie forms of widespread pain hypersensitivity, such as secondary hyperalgesia, pain amplification in uninjured sites.
The authors believe that the gliogenic LTP is a new form of paracrine synaptic plasticity. As any factor that activates glial cells, including stimulation or injury of peripheral nerve, spinal application of ATP, BDNF or opioid is able to induce the spinal LTP, the activation of glial cells and the subsequent release of gliotransmitters may be a common mechanism of the spinal LTP. HFS is only one approach to activating glial cells, and therefore the HFS-induced LTP is probably a special case (Fig. 2) .
Previously, the heterosynaptic LTP has been repeatedly demonstrated in spinal dorsal horn. HFS or injury of the tibial nerve induces LTP at C-fiber synapses innervated by the sural nerve [7] . HFS of C-fibers in the sciatic nerve also induces LTP at A-fiber synapses in the same nerve [8, 9] . P 2 X 7 receptors [10] , TNF-a [11] , interleukine-1 beta (IL1b) [12] and D-serine [9] have been shown critical for the spinal LTP. The novelty of the new work is that the gliotransmitters released in animals that receive HFS can induce LTP in naïve animals.
As proposed by authors, if gliogenic LTP also exists in other brain regions, it could be of relevance not only for pain but also for other disorders such as cognitive deficits, fear and stress disorders. It has been demonstrated that glial activation and the resultant increased release of gliotransmitters, such as TNF-a and IL-1b, promote LTP in spinal dorsal horn and pain sensitivity, but inhibit LTP in hippocampus and related memory (see [1] for a review). The mechanism underlying the CNS region-dependent synaptic plasticity is largely unknown. To clarify this issue, following questions should be answered. The types and amount of gliomitters released by glial cells in different regions should be determined in physiological and pathological conditions, as glial cells affect neuronal connectivity mainly by release of gliomitters. The effects of individual gliomitters and/or different combinations of them on synaptic plasticity should be uncovered. 
